Ticker Scorecard - NVCR Basics Company: NovoCure Limited Ordinary Shares IPO Date: September 28, 2015 Sector: Healthcare Industry: Medical Instruments and Supplies Market Cap: $2.39B Activated in VL: True Average Daily Range Avg Daily Range: $1.37 | 2.70% Avg Daily Range (30 D): $0.42 | 1.69% Avg Daily Range (90 D): $0.64 | 2.83% Institutional Daily Volume Avg Daily Volume: .76M Avg Daily Volume (30 D): .69M Avg Daily Volume (90 D): 1.01M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 61 Institutional Trades Total Inst.Trades: 4,792 Avg Inst. Trade: $3.65M Avg Inst. Trade (30 D): $2.3M Avg Inst. Trade (90 D): $2.23M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $5.71M Avg Closing Trade (30 D): $3.21M Avg Closing Trade (90 D): $3.23M Avg Closing Volume: 102.2K     News Dec 6, 2024 @ 1:32 PM Why NovoCure Stock Was Winning Big This Week Source: Eric Volkman Sep 6, 2024 @ 9:19 PM Why NovoCure Stock Dived by 13% This Week Source: Eric Volkman Jun 4, 2024 @ 1:01 PM A Closer Look at 7 Analyst Recommendations For Nov... Source: Benzinga Insights May 3, 2024 @ 5:00 AM NovoCure (NVCR) Q1 2024 Earnings Call Transcript Source: newsfeedback@fool.com (Motley Fool Transcribing) May 2, 2024 @ 9:01 PM Unveiling 8 Analyst Insights On NovoCure Source: Benzinga Insights Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.39 $-.28 $-.31 Diluted EPS $-1.39 $-.28 $-.31 Revenue $ 577.74M $ 155.1M $ 150.36M Gross Profit $ 441.47M $ 119.72M $ 115.7M Net Income / Loss $ -149.78M $ -30.57M $ -33.38M Operating Income / Loss $ -158.91M $ -32.09M $ -33.58M Cost of Revenue $ 136.27M $ 35.37M $ 34.65M Net Cash Flow $ 32.69M $ 20.76M $ -288.92M PE Ratio